Oncolytics Biotech® Completes Domicile Change to the United States
Oncolytics Biotech Inc., a clinical-stage biotech focused on the immunotherapeutic agent pelareorep, has completed its change of incorporation from Alberta, Canada to Nevada, USA. The shift reflects its predominantly U.S.-based investor and management profile and aims to streamline regulatory processes, enhance operational efficiency, and improve a…